Pharmacokinetics of Ceftazidime in Koi (Cyprinus carpio) After Single Dose Intramuscular or Intracoelomic Administration
IAAAM 2009
Pamela D. Govett1,2,3; Jennifer Buur1; Avery Krein1; Terry McDowell4; E. Scott Weber, III4
1Western University, College of Veterinary Medicine, Pomona, CA, USA; 2Environmental Medicine Consortium, North Carolina State University, College of Veterinary Medicine, Raleigh, NC, USA; 3California Science Center, Los Angeles, CA, USA; 4University of California, Davis, College of Veterinary Medicine, Davis, CA, USA


Ceftazidime pharmacokinetics were studied in adult koi (Cyprinus carpio) following single intramuscular (i.m.) and intracoelomic (i.ce.) injections. Twenty-two koi were divided into two groups. Eleven animals received 20 mg/kg ceftazidime i.m. and eleven received the same dose i.ce. Plasma ceftazidime concentrations were analyzed at predetermined intervals by reverse-phase high performance liquid chromatography. In the preliminary study, the Cmax was 41 µg/ml and the peak was seen at 12 hours post-i.m.-injection. The i.ce. administration demonstrated pharmacokinetics consistent with flip-flop kinetics and reached substantially lower peak plasma concentrations than the i.m. injection around 7 µg/ml. The i.m. concentration was above the minimum inhibitory concentration (MIC) values for Aeromonas hydrophilia and Renibacterium salmoninarum indicating that 20 mg/kg i.m. produces serum ceftazidime concentrations that are within a therapeutic range for koi.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Pamela D. Govett
Western University
College of Veterinary Medicine
Pomona, CA, USA


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357